Melis Anahtar
Co-founder @Day Zero Diagnostics, Inc A Biomérieux Company
Signup · Get unlimited contacts
WORK HISTORY
Co-founder @Day Zero Diagnostics, Inc A Biomérieux Company
Boston, MA, US
We are developing a rapid diagnostic using next-generation genome sequencing technologies and proprietary data-driven algorithms to rapidly identify bacterial species and predict drug resistance directly from clinical samples. Our diagnostic will allow physicians to prescribe the most effective antibiotic in hours rather than in days, as required by current culture based methods.
EDUCATION
Harvard Medical School
Doctor of Medicine (MD)
Harvard University
PhD, Immunology
University of Oxford
MSc, Integrated Immunology
Massachusetts Institute of Technology
SB, Mechanical Engineering
ABOUT MELIS ANAHTAR
Clinician Investigator at Mass General Hospital, Clinical Microbiologist, Co-founder of Day Zero Diagnostics
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.